Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

NCT03921736 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Hyperuricemia
Menopause

Interventions

DRUG: Perindopril
DRUG: Hydrochlorothiazide
DRUG: Estracomb TTS

Sponsor

Anna Posadzy-Małaczyńska